Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Argus Health
Julphar
Johnson and Johnson
US Department of Justice
Express Scripts
Farmers Insurance
McKinsey
Covington
Healthtrust

Generated: December 12, 2017

DrugPatentWatch Database Preview

Cefdinir - Generic Drug Details

« Back to Dashboard

What are the generic sources for cefdinir and what is the scope of cefdinir patent protection?

Cefdinir
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma, Lupin, Orchid Hlthcare, Sandoz, Teva Pharms, and Abbvie, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for cefdinir. Thirty suppliers are listed for this compound.

Pharmacology for cefdinir

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
AbbvieOMNICEFcefdinirCAPSULE;ORAL050739-001Dec 4, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
LupinCEFDINIRcefdinirCAPSULE;ORAL065264-001May 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LupinCEFDINIRcefdinirFOR SUSPENSION;ORAL065259-001May 31, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Orchid HlthcareCEFDINIRcefdinirCAPSULE;ORAL065418-001Jul 18, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozCEFDINIRcefdinirFOR SUSPENSION;ORAL065337-001Apr 6, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Orchid HlthcareCEFDINIRcefdinirFOR SUSPENSION;ORAL065429-002Jul 18, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva PharmsCEFDINIRcefdinirFOR SUSPENSION;ORAL065332-002May 4, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo PharmaCEFDINIRcefdinirCAPSULE;ORAL065434-001Jan 7, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozCEFDINIRcefdinirFOR SUSPENSION;ORAL065337-002Apr 6, 2007ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieOMNICEFcefdinirFOR SUSPENSION;ORAL050749-002Jul 29, 2004DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cefdinir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AbbvieOMNICEFcefdinirCAPSULE;ORAL050739-001Dec 4, 1997► Subscribe► Subscribe
AbbvieOMNICEFcefdinirFOR SUSPENSION;ORAL050749-002Jul 29, 2004► Subscribe► Subscribe
AbbvieOMNICEFcefdinirFOR SUSPENSION;ORAL050749-001Dec 4, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Covington
Cerilliant
Deloitte
Mallinckrodt
US Department of Justice
Queensland Health
Cantor Fitzgerald
QuintilesIMS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot